Identification of Stem Cells in Myeloid Malignancies - Opportunities for Discovery and Translation

In this webinar, Dr. Christopher Y. Park, NYU School of Medicine discusses the conceptual and experimental principles of leukemic stem cell isolation. He gives an overview on the use of human primary cells for in vitro assays and the generation of xenograft models of myeloid malignancies, and provides novel insights derived from the study of purified disease stem cells in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Publish Date: April 19, 2018

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.